Movano (Movano) Debt-to-Revenue

: N/A (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

Debt-to-Revenue measures a company's ability to pay off its debt.

Movano's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was $0.20 Mil. Movano's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was $0.00 Mil. Movano's annualized Revenue for the quarter that ended in Sep. 2023 was $0.00 Mil.

Movano Debt-to-Revenue Historical Data

The historical data trend for Movano's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Movano Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Debt-to-Revenue

N/A

Movano Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Debt-to-Revenue													N/A	N/A	N/A	N/A	N/A

Competitive Comparison

For the Medical Devices subindustry, Movano's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Movano Debt-to-Revenue Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Movano's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Movano's Debt-to-Revenue falls into.

Movano Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Movano's Debt-to-Revenue for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0.212	+	0.214)	/	N/A
	=	N/A

Movano's annualized Debt-to-Revenue for the quarter that ended in Sep. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0.204	+	0)	/	0
	=	N/A

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Sep. 2023) Revenue data.

Movano Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Movano's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Movano (Movano) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Movano Inc (NAS:MOVE) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

6800 Koll Center Parkway, Pleasanton, CA, USA, 94566

Website

https://www.movano.com

Movano Inc is a health-focused technology company developing simple, smart, and personalized devices designed to help individuals on their health journey maintain good health today and prevent and manage chronic diseases in the future. It is developing a proprietary platform that uses Radio Frequency (RF) technology. It enables the creation of low-cost and scalable sensors that fit into wearable and other small form factors.

Executives

Jeremy Cogan	officer: CFO	6800 KOLL CENTER PARKWAY, PLEASANTON CA 94566
Michael Aaron Leabman	director, officer: CEO and President	207 VERITAS CT, SAN RAMON CA 94582
Emily Fairbairn	director	10 ORINDA VIEW ROAD, ORINDA CA 94563
John Mastrototaro	director	6800 KOLL CENTER PARKWAY, PLEASANTON CA 94566
Brian Cullinan	officer: CFO	6800 KOLL CENTER PARKWAY, PLEASANTON CA 94566
Nan Kirsten Forte	director	111 EIGHTH AVENUE, NEW YORK NY 10011
Ruben Caballero	director	C/O RESONANT INC. 10900 STONELAKE BLVD., SUITE 100, OFFICE 02-130, AUSTIN TX 78759
Dvine Irrevocable Trust	10 percent owner	6200 STONERIDGE MALL RD., SUITE 300, PLEASANTON CA 94588
Gregory S Tamkin	10 percent owner	303 RAY STREET, PLEASANTON CA 94566
Dorsey & Whitney Trust Co Llc	10 percent owner	401 EAST EIGHTH STREET, SUITE 319, SIOUX FALLS SD 57103
William Tai-wei Ho	10 percent owner	C/O IN8BIO, INC., 79 MADISON AVENUE, NEW YORK NY 10016